Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -252.32% | $ -164.22M | $ 65.08M |
3/31/2025 | -36.31% | $ -65.23M | $ 179.64M |
12/31/2024 | -38.62% | $ -68.76M | $ 178.03M |
9/30/2024 | -25.76% | $ -45.1M | $ 175.04M |
6/30/2024 | -54.47% | $ -77.05M | $ 141.46M |
3/31/2024 | -1038.56% | $ -190.66M | $ 18.36M |
12/31/2023 | -231.82% | $ -139.74M | $ 60.28M |
9/30/2023 | -164.79% | $ -117.13M | $ 71.08M |
6/30/2023 | -160.37% | $ -113.48M | $ 70.77M |
3/31/2023 | -157.82% | $ -112.33M | $ 71.17M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: Op. Inc. [ $ -126.25M ] / Revenues [ $ 3.18M ]
(=) Operating % [ -3965.04% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |